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Abstract 
Abdominal angioedema attacks are a frequent and typical symptom of hereditary angioedema (HAE) but very often 
generate diagnostic problems. The study presents laboratory and clinical findings of 7 patients with HAE 1/2 
hospitalized due to severe attacks. In all cases, at admittance severe abdominal pain, flatulence, strong weakness, 
different grade of nausea/vomiting or diarrhoea and abundant free fluid in peritoneal cavity were present. In the 
history of all patients, recurrent 2 to 3 day long abdominal attack with ascites, were announced. Laboratory data 
done before the treatment showed elevated leukocytosis, hematocrit, serum glucose, high D-dimers and decreased 
value of APTT. All patients had an abdominal ultrasound examination, in 5 patients additional abdominal angio-CT 
was performed to exclude thromboembolic episode. The infusion of human C1 inhibitor concentrate was 
administered as causative treatment. Completely withdrawal of symptoms was noted up to72 hrs after infusion. In 
addition all laboratory parameters normalized as well as the free fluid in abdominal cavity disappeared, however, D-
dimers serum level despite a decreasing tendency reached the normal range just after 2 weeks. 
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1. Introduction 
Hereditary angioedema (HAE) is one of bradykinin dependent edema. Is inherited in an autosomal dominant 
manner. It is caused by one of more than 450 different mutations in SERPING1 gene, which codes C1 inhibitor (C1-
INH). The new mutations in first patient’s generation are responsible for the diseases in approximately 20-25% of 
cases. There are two types of HAE. The first type (HAE 1) is associated with the lack of C1-INH protein and the 
second type (HAE 2) with decreased activity of C1-INH. The estimated disease incidence is 1 in 50,000 individuals 
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and varies depending on the region [1-3]. During the course of both types of HAE, the attacks of angioedema are 
localized in the skin or mucous of the respiratory and gastrointestinal tract [4, 5]. The bradykinin angioedema attack 
differs from other swellings, including the most common histamine- dependent swelling, in longer duration, slower 
build-up phase, lack of urticaria, lack of pruritus and presence of prodromal symptoms [3]. Abdominal attacks are 
one of the most common forms of HAE. Intestine oedema leads to partial or complete bowel obstruction. Abdominal 
attack symptoms are pain, nausea, vomiting and diarrhoea. It might lead to hypovolaemia and shock. Both 
abdominal and laryngeal attacks are life-threatening conditions. In the past, surgical treatment of HAE abdominal 
attacks was the most common mistake as a result of lack of, or wrong differential diagnosis [4, 5]. The typical 
edema treatment, like anti- histamine drugs, systemic steroids or adrenaline in bradykinin dependent edema, is 
ineffective. It requires administration of human or recombinant C1-INH, a bradykinin receptor blocker or a 
kallikrein inhibitor. Late drug administration affects the slower regression of symptoms and may complicate the 
differential diagnosis of other causes of acute abdominal pain [3]. Physicians at the emergency units may face these 
problems. The aim of the study was the retrospective analysis of patients with HAE abdominal attacks who were 
hospitalized due to the severity of the attacks.  
 
2. Materials and Methods 
Seven adult patients (5 women & 2 men between the age of 18 to 57 years) with C1-INH HAE type 1/2, diagnosed 
and treated in our outpatient HAE Center, were enrolled in the study. They fulfilled the criteria of prolonged 
hospitalization over 24 hours due to very severe abdominal attacks. Their clinical characteristic are summarized in 
Table 1. Family history was positive in 4 patients. The mean age of the first onset of angioedema was 8.7 yrs ( 3-15 
yrs). In all patients case history revealed the presence of 2 to 4 days long abdominal attacks followed by efficient 
treatment with the infusion of C1-INH concentrate. In 4 cases, abdominal symptoms were connected with recurrent 
ascites, disappearing together with the abdominal symptoms. In 2 patients (no 2 & 6) abdominal attacks were the 
only symptom of the disease. The diagnosis of C1-INH HAE type 1 or 2 was based on; case and family history, and 
an estimation of antigenic C1-INH C4 level as well as functional C1-INH. The C1-INH and C4 serum levels were 
determined during remission using the nephelometric metod on Behring Nephelometr 100 analizator. Activity of C1 
inhibitor (fC1-INH) was measured with the colorimetric kinetic method using a chromogen substract (Berichrom C1 
Inhibitor &Komplement Reagents - DADE Behring) on Behring Coagulation Timer analyser. 
 
Medical history from local emergency units was analysed. At admission, the general state of patients was very 
serious because of the abdominal pain, weakness and flatulence, diarrhea or vomiting. In 3 patients, besides severe 
abdominal symptoms, peripheral angioedema was present. Clinical symptoms were evaluated from the medical 
history using the popular symptom score (no symptoms, mild, moderate and severe) with a scale of 0 to 3. 
Laboratory tests of white blood cells (WBC), hematocrit (Hct), C-reactive protein (CRP), serum glucose level, 
APTT and D-dimers serum level was determined and abdominal ultrasonography (abdominal USG) was conducted. 
All clinical symptoms, laboratory and ultrasonography were analysed twice; at admission and after the 72 hours.  
Five cases (case no 1-5) required angiography computed tomography (A-CT), at admission, in order to exclude 
thrombosis in visceral vessels. 
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No sex  Age at the time of 
hospitalization  
aC1-INH* 
  
fC1-INH** C4*** HAE 
type 
Family 
history 
Age (years) / location of first 
HAE attack 
Main and additional HAE attack 
location 
1. F 57  0.09  30.6 0.016 1 positive 15 - hand abdomen, arm 
2. M 32 0.06  35.8 0.09 1 positive 10 - abdomen abdomen 
3. F 30 0.37 19 0.02 2 negative 10 - face abdomen 
4. F 25 0.05  9.3 0.049 1 negative  3 - hand abdomen, hand, face 
5. F 51 0.03 18.6 0 1 positive 10 - abdomen abdomen, face 
6. M 18 0.12 45 0.1 1 positive  5 - abdomen abdomen 
7. F 34 0.08 34 0.05 1 positive 8 - abdomen abdomen 
*aC1-INH: C1-INH antigen - normal range 0.2-0.39 g/L, **fC1-INH: C1-INH functional normal range 70-130%, ***C4: normal range 0.1-0.4 g/L 
 
Table 1: Clinical and biochemical characteristic of the patients. 
 
No  Leukocytosis 
 *>** 
Htc 
*>** 
CRP mg/L  
* >** 
D-dimers  
 *>** 
APTT - s 
*>** 
Serum glucose  
mg% *>** 
Abdominal  
USG *>** 
Symptoms score 
*>** 
Angio CT 
1 18 300 > 4 100 54.8 >36.1 2.9 > 3.5  8 457 > 1 527 25.2> 26 134 > 74  + > 0  3 > 0  Neg.  
2 12 780 > 5 460 48>47,5 8.2 > 1.0 6 630 > 2 860 270*** 24.2 > 24 146 > 78 + > 0 3 > 0 Neg. 
3 19 300 > 4 970 47,4>36,4 30.1>1.7  13370 > 1 538 207*** 23.5 >24 127 > 80 +>trace 3 > 1 Neg. 
4 10 800 > 7 300 40,5>33,6 8.1 > 1.7  34000 > 2 389 550*** 22 > 25  120 > 85  +>trace  3 > 1  Neg. 
5 8 510 >5 700 39.2 >34,7 3.5 > 3.2 16000 > 955 507*** 22 > 26 137 > 90 + > 0 3 > 0 Neg. 
6 21 820>12 800 5790 *** 52.4> 42  170> 66 3.06 *** 5990>1 230 250 *** 30.5>31.5 108> 97,2 + >trace 3>0 n.d. 
7 17 500> 6 300 56.5> 41,5 18.2> 3,45  nd 29.7> 32 118,7> 85 +> 0 3>0 n.d. 
 N: 4-10 000 uL N: 35-45 % N <5.0 mg/l N <500 ug/ml N: 26-32  
 Sec. 
N:70-99 
 mg%  
Abundant fluid 
in peritoneal 
cavity 
0-no symtoms,  
1-milde, 
2-moderate, 
3-severe. 
Presence of 
trombo-
embolism 
*: at admission, **: after 72 hrs, *** 2 weeks later, nd – not done, N- norm 
Table 2: Laboratory parameters symptoms score and treatment at the beginning of admission to the hospital and after 72 hrs. of hospitalization. 
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3. Results 
Results of the study are presented in Table 2. In all 7 patients at admission a high symptoms’ score of 3 was noted 
because of severe abdominal pain, strong flatulence, weakness, diarrhea or vomiting. In cases no 1, 2, 3, 6 and 7 
strong weakness was observed with hypotension. In 3 cases (no 1,4 and 5) additional attacks of peripheral skin 
angioedema (face, arm, hand) were present. The image of abdominal cavity and small pelvis ultrasonography 
revealed the presence of significant amounts of intra-abdominal fluid and 4 cases exhibited regional bowel edema. 
In all cases, at admission, high leukocytosis, hematocrit and elevated glucose serum levels were noted as well as 
very high D-dimers serum level. In 5 cases (no 2,3,4, 6 & 7) CRP was elevated (in case no 6 the increase of CRP 
was extremely high). In cases 1 through 5 the value of APTT was somewhat decreased.  
 
All patients received infusion of C1-INH concentrate at the hospital. In 5 cases (no 1-3 & 6 and 7) additional 
infusion of fluid was necessary because of dehydration symptoms and decreasing blood pressure. In all cases, time 
from the onset of symptoms was no longer than 4 hours. Symptoms which patients had at the time of attack 
gradually diminished after the infusion, but complete resolution was observed not sooner than at the 72 hour control 
exam. In addition, the 72 hour control exam revealed leucocytosis, Htc and serum glucose levels which returned to 
norm. Initial elevated CRP levels noted in cases no 2,3,4 and 7 also normalized. Only in case no 6, with extremely 
severe symptoms, pain localized in the appendix region, and the highest value of CRP at admission, the CRP 
decreased to 66 mg/l despite the disappearance of all abdominal symptoms. The complete normalization of this 
parameter in this patient was noted two weeks later without any additional medical intervention. Very high D-dimers 
serum level were revealed in 6 patients at admission and remained high. Their level normalized at the control exam 
performed 2 weeks later (Table 2). In 5 cases the slightly decreased APTT values returned to norm. In all patients, 
abdominal ultrasonography at admission revealed the presence of abundant fluid in the peritoneal cavity. No fluid in 
4 cases and trace amounts in 3 cases were revelled after 72 hours. 
 
In 5 cases (1-5) the angio-CT examination was done to exclude thromboembolic changes in visceral vessels due to 
severe clinical symptoms, high D-dimers, and slow regression. The result was negative. 
 
4. Discussion  
The current recommendation is that attacks are treated as early as possible. Early treatment is associated with shorter 
time to resolution of symptoms and shorter total attack duration regardless of attack severity and localization. All 
patients with HAE -1&2 should be considered for at-home therapy and self-administration training [3]. In our group 
of patients, late drug administration in hospital was probably one of the reasons of severity and prolonged duration 
of attacks. Despite adequate treatment, the course of the attacks may be more severe. It often requires 
hospitalization, additional test and examinations [5-7].  
 
A severe course of abdominal attack is a result of pain and vasodilation, massive fluid extravasation with edema of 
the bowel wall. Ascites, as well as the fluid loss due to vomiting and diarrhea, may lead to considerable 
hypovolemia and hemoconcentration. When this process occurs rapidly, is responsible for the clinical circulatory 
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symptoms ranging from light headedness to shock of variable severity. Bork and all showed that a circulatory 
collapse occurred in 4.4% of all attacks. Dehydration was the explanation for high: leucocytosis, Htc and glucose in 
patients no 1,2,3, 6,7 [5]. 
 
CRP values in 4 cases (no 2,3,4 and 7) were significantly elevated and returned to the norm with disappearance of 
the symptoms. A Japanese study by Ohasawa et al. concluded that the CRP values during the course of the HAE 
attack should remain normal [8]. In their opinion CRP is one of the parameters that facilitate differential diagnosis 
with other acute abdomen reasons. Hofman et al. showed different results CRP levels were elevated in a substantial 
proportion of asymptomatic HAE patients and increase significantly during an abdominal attack. The possible 
explanation is low-grade systemic inflammatory reactions – cytokine mediated CRP liver production- in HAE 
patients as well as a triggering event for attacks that starts prior to symptom onset [9].  
 
High level of D-dimers and decreased value of APTT was observed at the admission to hospital in 6 and 5 patients 
respectively. These observations confirm the study results of Reshef et al. [10], indicating that elevated D-dimer 
level is often associated with the initial phase of acute submucosal/abdominal attack of HAE normalizing gradually 
together with withdrawal of symptoms. In HAE patients the absence of normal inhibition by C1-INH increased 
fibrinolytic activity during attacks and even in remissions [11-17]. Shortened APTT is a consequence of the C1-INH 
deficiency and a sign of the latent activation of the kallikrein-kinin system and the intrinsic clotting system [18]. 
Inflammation and an acute phase reaction may result in APTT decrease. In clinical practice, elevated plasma D-
dimers are considered biomarkers of extensive thrombosis but are also elevated in certain nonpathologic conditions 
[19]. Despite evidence of extensive activation of both coagulation–contact and fibrinolytic systems, relatively low 
rates of spontaneous thromboembolic events have been reported in patients with C1-INH HAE [10]. In our group of 
patients with elevated CRP and D-dimers together with severe course of attacks needed additional examinations 
(USG, angio-CT) to exclude thromboembolic events and inflammations. Typical imaging examinations findings 
confirming abdominal HAE attacks are thickened bowel wall and ascites [20-23]. CT and angio-CT is the most 
exact, but not always available imaging modality confirming the abdominal HAE attack and excluding 
thromboembolic events [24, 25]. In recurrent and frequent abdominal attacks ultrasound may be able to reduce 
cumulative ionizing radiation exposure from repeated CT. Ultrasounds allow for rapid assessment of patients, with 
HAE, who complain about abdominal pain and can also be useful in excluding other diagnoses such as appendicitis, 
ectopic pregnancy, and biliary disease [20-23].  
  
5. Conclusions 
1. HAE abdominal attacks despite casual treatment, can be severe and requiring hospitalization. 
2. There are findings both in laboratory tests and USG examination confirming dehydration and displacement 
of fluids during an attack.  
3. Imaging tests (USG, CT) confirm the abdominal HAE attack. Elevated CRP and D-dimers are very often 
present, but there is no specific laboratory test for the HAE abdominal attack. All possible tests should be 
performed to exclude other diagnosis in patients with severe abdominal HAE attacks. 
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